Unknown

Dataset Information

0

A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state.


ABSTRACT: To examine the efficacy of ziprasidone vs. placebo for the depressive mixed state in patients with bipolar disorder type II or major depressive disorder (MDD).73 patients were randomized in a double-blinded, placebo-controlled study to ziprasidone (40-160 mg/d) or placebo for 6 weeks. They met DSM-IV criteria for a major depressive episode (MDE), while also meeting 2 or 3 (but not more nor less) DSM-IV manic criteria. They did not meet DSM-IV criteria for a mixed or manic episode. Baseline psychotropic drugs were continued unchanged. The primary endpoint measured was Montgomery-Åsberg Depression Rating Scale (MADRS) scores over time. The mean dose of ziprasidone was 129.7±45.3 mg/day and 126.1±47.1 mg/day for placebo.The primary outcome analysis indicated efficacy of ziprasidone versus placebo (p?=?0.0038). Efficacy was more pronounced in type II bipolar disorder than in MDD (p?=?0.036). Overall ziprasidone was well tolerated, without notable worsening of weight or extrapyramidal symptoms.There was a statistically significant benefit with ziprasidone versus placebo in this first RCT of any medication for the provisional diagnostic concept of the depressive mixed state.Clinicaltrials.gov NCT00490542.

SUBMITTER: Patkar A 

PROVIDER: S-EPMC3335844 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Objective</h4>To examine the efficacy of ziprasidone vs. placebo for the depressive mixed state in patients with bipolar disorder type II or major depressive disorder (MDD).<h4>Methods</h4>73 patients were randomized in a double-blinded, placebo-controlled study to ziprasidone (40-160 mg/d) or placebo for 6 weeks. They met DSM-IV criteria for a major depressive episode (MDE), while also meeting 2 or 3 (but not more nor less) DSM-IV manic criteria. They did not meet DSM-IV criteria for a mixe  ...[more]

Similar Datasets

| S-EPMC4843798 | biostudies-literature
| S-EPMC6587371 | biostudies-literature
| S-EPMC3044623 | biostudies-literature
| S-EPMC3268840 | biostudies-literature
| S-EPMC3327857 | biostudies-other
| S-EPMC4848251 | biostudies-literature
| S-EPMC2719441 | biostudies-literature
| S-EPMC10666694 | biostudies-literature
| S-EPMC4576018 | biostudies-literature
| S-EPMC10835052 | biostudies-literature